23andMe expands collaboration with Genentech

01/31/2013 | GenomeWeb Daily News (free registration)

23andMe is asking for saliva samples from any U.S. patient who used Avastin before this year to treat certain metastatic cancers. Study participants will be asked to send a saliva sample and may also submit a blood sample for genetic analysis, and will complete five online surveys throughout the year. The study, called InVite, aims to identify new genetic markers for the diseases and to understand differences in patient response.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Director, Payer Marketing
Avalere Health
Washington, DC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX